Yuxuan Wu
Shanghai Key Laboratory Of Regulatory Biology
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Author Correction: Increasing the efficiency and targeting range of cytidine base editors through fusion of a single-stranded DNA-binding protein domain.
Journal: Nature cell biology
Published: June 17, 2026
CasY7: An optimized Cas12i system for enhanced genome editing in monocot crops.
Journal: Journal of integrative plant biology
Published: November 30, 2025
Genome editing or small molecule inhibition of KMT5A in CAR-T cells enhances antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: August 22, 2025
Prdm12 governs an epigenetic checkpoint linking neuroimmune cross-talk to CD8+ T cell exhaustion-suppressed antitumor immunity.
Journal: Science advances
Published: August 15, 2025
Spleen-targeted NeoPol-mL242 mRNA vaccine induces robust T-cell responses in a hepatocellular carcinoma model.
Journal: Journal of nanobiotechnology
Published: June 14, 2025
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial.
Journal: Nature medicine
Published: May 20, 2025
CRISPR-Cas9-mediated uATG introduction in the 5'UTR of the Uox gene for hyperuricemia mouse models: implications for gout and metabolic disorders.
Journal: Science China. Life sciences
Published: March 29, 2025
Lentiviral vectors for gene therapy of α-thalassemia.
Journal: Science China. Life sciences
Published: October 08, 2024
In vivo genome editing of human haematopoietic stem cells for treatment of blood disorders using mRNA delivery.
Journal: Nature biomedical engineering
Published: April 29, 2024
Gene Editing in Hematopoietic Stem Cells.
Journal: Advances in experimental medicine and biology
Published: January 16, 2024
Last Updated: 09/26/2026